Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report

doi:10.12998/wjcc.v7.i16.2316

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4682)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

336

WORD

209

HTML

2161

Figures (1-2)

157

Tables (1-1)

155

Sum=3018

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

590

Download

1074

Sum=1664

Aug 26, 2019 (publication date) through May 4, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 26, 2019; 7(16): 2316-2321
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2316

Open in New Tab Full Size Figure Download Figure

Figure 1 Fifteen weeks after vedolizumab treatment.

Open in New Tab Full Size Figure Download Figure

Figure 2 Before vedolizumab treatment.

Citation: Cakir OO. Effectiveness of vedolizumab treatment in two different anti-tumor necrosis factor alpha refractory pouchitis: A case report. World J Clin Cases 2019; 7(16): 2316-2321
URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2316.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i16.2316